Published in Gene Therapy Weekly, September 25th, 1995
Isis and Ciba are targeting filing an IND by the end of 1995 to commence Phase I clinical trials of ISIS 3521.
The broadened collaboration will also include research to discover additional therapeutic compounds targeting isotypes of the multi-gene family, PKC, and development of these compounds. Isotypes of PKC are implicated in a broad range of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.